Lyell Immunopharma, Inc. (LYEL)
Largest Insider Buys in Sector
LYEL Stock Price History Chart
LYEL Stock Performance
About Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate population of T cells with durable stemness. Its pipeline includes LYL797, a T cell product candidate for the treatment of non-small cell lung cancer and triple negative breast cancers; LYL845, that targets multiple solid tumors; and NY-ESO-1 for synovial sarcoma and other solid tumor indications. The company entered into research and development collaboration and license agreement with GlaxoSmithKline for NY-ESO-1 program. Lyell Immunopharma, Inc. was incorporated in 2018 and is headquartered in South San Francisco, California.
Insider Activity of Lyell Immunopharma, Inc.
Over the last 12 months, insiders at Lyell Immunopharma, Inc. have bought $0 and sold $132,286 worth of Lyell Immunopharma, Inc. stock.
On average, over the past 5 years, insiders at Lyell Immunopharma, Inc. have bought $300,016 and sold $132,286 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 17,648 shares for transaction amount of $300,016 was made by FRIEDMAN CATHY (director) on 2021‑06‑21.
List of Insider Buy and Sell Transactions, Lyell Immunopharma, Inc.
| 2023-08-15 | Sale | Klausner Richard | director | 58,020 0.0231% | $2.28 | $132,286 | -9.17% | |
| 2021-06-21 | FRIEDMAN CATHY | director | 17,648 0.0422% | $17.00 | $300,016 | -50.33% |
Insider Historical Profitability
| Klausner Richard | director | 930880 0.3696% | $1.31 | 0 | 1 | |
| FRIEDMAN CATHY | director | 17648 0.007% | $1.31 | 1 | 0 | <0.0001% |
Institutional Investor Ownership
| Mwg Management Ltd | $44.96M | 7.91 | 20.16M | 0% | +$0 | 33.29 | |
| Orland Properties Ltd | $33.66M | 5.92 | 15.09M | 0% | +$0 | 19.04 | |
| BlackRock | $30.98M | 5.45 | 13.89M | -2.86% | -$913,392.41 | <0.01 | |
| The Vanguard Group | $29.86M | 5.25 | 13.39M | -1.58% | -$480,792.46 | <0.01 | |
| GOLDEN CAPITAL MANAGEMENT LLC | $18.56M | 3.27 | 8.32M | 0% | +$0 | 10.78 | |
| T. Rowe Price | $15.01M | 2.64 | 6.73M | +1.4% | +$206,509.47 | <0.01 | |
| Alphabet | $13.08M | 2.3 | 5.87M | 0% | +$0 | 0.52 | |
| Geode Capital Management | $8.96M | 1.58 | 4.02M | +2.02% | +$177,684.54 | <0.01 | |
| State Street | $8.29M | 1.46 | 3.72M | +5.05% | +$398,895.69 | <0.0001 | |
| Opaleye Management Inc | $7.48M | 1.32 | 3.35M | New | +$7.48M | 1.18 | |
| Sc China Holding Ltd | $7.43M | 1.2 | 3.05M | 0% | +$0 | 0.6 | |
| Fidelity Investments | $6.18M | 1.09 | 2.77M | -0.7% | -$43,406.95 | <0.0001 | |
| Millennium Management LLC | $4.54M | 0.8 | 2.04M | +126.54% | +$2.54M | <0.01 | |
| Mic Capital Management Uk Llp | $3.88M | 0.68 | 1.74M | 0% | +$0 | 0.74 | |
| Massachusetts Financial Services Co Ma | $3.44M | 0.6 | 1.54M | +13.74% | +$415,141.24 | <0.01 | |
| Northern Trust | $3.22M | 0.57 | 1.44M | -2.27% | -$74,791.97 | <0.01 | |
| Charles Schwab | $2.85M | 0.5 | 1.28M | +0.99% | +$27,984.27 | <0.01 | |
| Td Asset Management Inc | $2.15M | 0.38 | 963,842 | +5.2% | +$106,170.32 | <0.01 | |
| Invenomic Capital Management LP | $1.94M | 0.34 | 871,525 | +16.76% | +$278,995.34 | 0.1 | |
| Nuveen | $1.9M | 0.33 | 852,055 | +16.8% | +$273,319.86 | <0.01 | |
| Citadel Advisors LLC | $1.75M | 0.31 | 786,344 | -77.39% | -$6M | <0.01 | |
| JPMorgan Chase | $1.46M | 0.26 | 654,622 | +302.61% | +$1.1M | <0.0001 | |
| Baillie Gifford Co | $1.46M | 0.26 | 656,157 | -5.03% | -$77,412.21 | <0.01 | |
| BNY Mellon | $1.41M | 0.25 | 633,479 | -4.17% | -$61,409.69 | <0.0001 | |
| Canada Pension Plan Investment Board | $1.31M | 0.23 | 588,235 | 0% | +$0 | <0.01 | |
| Morgan Stanley | $1.22M | 0.21 | 545,367 | -0.41% | -$4,972.90 | <0.0001 | |
| The Manufacturers Life Insurance Company | $1.08M | 0.19 | 483,451 | +4.12% | +$42,650.99 | <0.01 | |
| Two Sigma | $955,756.00 | 0.17 | 428,590 | +77.48% | +$417,242.05 | <0.01 | |
| Goldman Sachs | $949,255.00 | 0.17 | 425,675 | -32.18% | -$450,504.48 | <0.0001 | |
| Renaissance Technologies | $944,000.00 | 0.17 | 423,500 | +484.14% | +$782,394.33 | <0.01 | |
| Invesco | $912,976.00 | 0.16 | 409,406 | +31.6% | +$219,202.46 | <0.0001 | |
| Clarius Group Llc | $890,145.00 | 0.16 | 399,168 | 0% | +$0 | 0.07 | |
| D. E. Shaw & Co. | $833,141.00 | 0.15 | 373,606 | New | +$833,141.00 | <0.01 | |
| Susquehanna International Group | $630,151.00 | 0.11 | 282,579 | -41.05% | -$438,868.34 | <0.01 | |
| RhumbLine Advisers | $620,309.00 | 0.11 | 278,171 | +2.69% | +$16,247.46 | <0.01 | |
| Swiss National Bank | $551,702.00 | 0.1 | 247,400 | 0% | +$0 | <0.0001 | |
| ExodusPoint Capital Management, LP | $547,000.00 | 0.1 | 245,083 | +381.44% | +$433,383.05 | 0.01 | |
| American Century Investments | $527,781.00 | 0.09 | 236,673 | +62.72% | +$203,438.52 | <0.0001 | |
| Balyasny Asset Management Llc | $527,961.00 | 0.09 | 236,754 | New | +$527,961.00 | <0.01 | |
| Bank of America | $489,443.00 | 0.09 | 219,481 | -86.78% | -$3.21M | <0.0001 | |
| UBS | $444,167.00 | 0.08 | 199,178 | -8.98% | -$43,846.27 | <0.0001 | |
| OrbiMed | $444,885.00 | 0.08 | 199,500 | New | +$444,885.00 | 0.01 | |
| Jane Street Capital | $417,556.00 | 0.07 | 187,245 | -38.42% | -$260,517.30 | <0.0001 | |
| New York Life Investment Management Llc | $409,885.00 | 0.07 | 183,805 | +24.64% | +$81,033.71 | <0.01 | |
| Caxton Associates | $389,485.00 | 0.07 | 174,657 | +359.07% | +$304,642.44 | 0.03 | |
| AllianceBernstein | $389,871.00 | 0.07 | 174,830 | -5.11% | -$21,006.60 | <0.0001 | |
| BBR Partners | $365,811.00 | 0.06 | 164,041 | 0% | +$0 | 0.03 | |
| Barclays | $326,000.00 | 0.06 | 146,541 | -44.3% | -$259,234.30 | <0.0001 | |
| Shell Asset Management Co | $310,000.00 | 0.06 | 138,958 | -3.5% | -$11,228.07 | 0.01 | |
| CalSTRS | $291,196.00 | 0.05 | 130,581 | -6.81% | -$21,283.15 | <0.0001 |